Michael W. Deininger, MD, PhD
Professor and Chief of Hematology and Hematologic MalignanciesDepartment of Internal Medicine and the Huntsman Cancer Institute
University of Utah
- Next Steps After TKIs for Patient With Chronic-Phase CML?
Saturday, September 1st, 2018
This month, Michael Deininger, MD, PhD, discusses treatment for a patient with chronic-phase chronic myeloid leukemia (CML) whose BCR/ABL transcript levels are rising. And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!
- How to treat an older patient with CML and a sudden ANC drop?
Thursday, June 1st, 2017
This month, Michael W. Deininger, MD, PhD, discusses myelosuppression in a patient with chronic myeloid leukemia. And don't forget to check out next month's clinical dilemma - send in your responses for a chance to win an ASH Clinical News-themed prize!
